Last update 01 Nov 2024

SciPharm SARL

Subsidiary Company|
2010|
Grevenmacher, Luxembourg
|
www.scipharm.eu

Overview

Tags

Immune System Diseases
Hemic and Lymphatic Diseases
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases1
Immune System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
PGI2 receptor(Prostanoid IP receptor)1

Related

1
Drugs associated with SciPharm SARL
Treprostinil sodium
Target
PGI2 receptor
Mechanism
PGI2 receptor agonists
Active Org.
Pharmosa Biopharm, Inc. [+6]
Originator Org.
United Therapeutics Corp.United Therapeutics Corp.
Active Indication
Hypertension, Pulmonary [+9]
Inactive Indication
Anemia, Sickle Cell [+14]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date21 May 2002
1
Clinical Trials associated with SciPharm SARL
NCT01416636 / CompletedPhase 3
A Double Blind Controlled Clinical Study to Investigate the Efficacy and Tolerability of Subcutaneous Treprostinil Sodium in Patients With Severe Non-operable Chronic Thromboembolic Pulmonary Hypertension (CTREPH)
100 Clinical Results associated with SciPharm SARL
Login to view more data
0 Patents (Medical) associated with SciPharm SARL
Login to view more data
100 Deals associated with SciPharm SARL
Login to view more data
100 Translational Medicine associated with SciPharm SARL
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Treprostinil sodium
 ( PGI2 receptor )		Chronic thromboembolic pulmonary hypertension
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free